Chronic Kidney Disease Clinical Trials in Erlangen, Bavaria
3 recruitingErlangen, Bavaria, Germany
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Chronic Kidney DiseaseProteinuriaChildren
Bayer100 enrolled178 locationsNCT05457283
Recruiting
Not Applicable
Smart and Fit for Kidney Transplantation
Chronic Kidney Disease Requiring Chronic Dialysis
University of Erlangen-Nürnberg Medical School200 enrolled1 locationNCT06040281
Recruiting
Phase 4
Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation
Chronic Kidney Diseases
University of Erlangen-Nürnberg Medical School48 enrolled1 locationNCT06560801